These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 30981947)

  • 1. Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study.
    Thauvin C; Widmer J; Mottas I; Hocevar S; Allémann E; Bourquin C; Delie F
    Eur J Pharm Biopharm; 2019 Jun; 139():253-261. PubMed ID: 30981947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.
    Yuan H; Gui H; Chen S; Zhu L; Wang C; Jing Q; Lv H; Wan Q; Wang S; Zhou S; Ren X; Nie Y; Li L
    Int J Nanomedicine; 2024; 19():3589-3605. PubMed ID: 38645464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy.
    Rodell CB; Ahmed MS; Garris CS; Pittet MJ; Weissleder R
    Theranostics; 2019; 9(26):8426-8436. PubMed ID: 31879528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors.
    Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT
    Front Immunol; 2023; 14():1334800. PubMed ID: 38259462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
    Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
    ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.
    Duong AD; Sharma S; Peine KJ; Gupta G; Satoskar AR; Bachelder EM; Wyslouzil BE; Ainslie KM
    Mol Pharm; 2013 Mar; 10(3):1045-55. PubMed ID: 23320733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy.
    Dang BN; Duwa R; Lee S; Kwon TK; Chang JH; Jeong JH; Yook S
    J Control Release; 2024 Jun; 372():587-608. PubMed ID: 38942083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer.
    Zhou J; Xu Y; Wang G; Mei T; Yang H; Liu Y
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35552764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPGS nanoparticles co-loaded with ABT-737 and R848 for breast cancer therapy.
    Lang X; Wang X; Han M; Guo Y; Dong Z
    Biomed Pharmacother; 2024 Jul; 177():117107. PubMed ID: 38996708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale coordination polymer synergizes photodynamic therapy and toll-like receptor activation for enhanced antigen presentation and antitumor immunity.
    Jiang X; Liu J; Lee MJ; Peng C; Luo T; Tillman L; Weichselbaum RR; Lin W
    Biomaterials; 2023 Nov; 302():122334. PubMed ID: 37776767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Petaloid Metal-Organic Frameworks for Resiquimod Delivery To Potentiate Antitumor Immunity.
    Zhang C; Deng Z; Sun X; Yuan K; Wang J; Wu X; Zhang Y; Yang K; Zhang J; Yang G
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33093-33105. PubMed ID: 38884171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
    Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
    Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activable Nano-Immunomodulator Assembled from π-Extended Naphthalenediimide for Precision Photothermal Immunotherapy.
    Zhong W; Yuan W; Chen Y; Ma Z; Ma M; Tan BSN; Yang J; Zhao Y
    Angew Chem Int Ed Engl; 2024 Jun; 63(23):e202401250. PubMed ID: 38576254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer.
    Pauli G; Chao PH; Qin Z; Böttger R; Lee SE; Li SD
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomaterials-Mediated Co-Stimulation of Toll-Like Receptors and CD40 for Antitumor Immunity.
    Yan J; Zhang Y; Du S; Hou X; Li W; Zeng C; Zhang C; Cheng J; Deng B; McComb DW; Zhao W; Xue Y; Kang DD; Cheng X; Dong Y
    Adv Mater; 2022 Nov; 34(47):e2207486. PubMed ID: 36121735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Immunotherapy with Micellar Resiquimod-Polymer Conjugates Triggers a Robust Antitumor Response in a Breast Cancer Model.
    Kakwere H; Zhang H; Ingham ES; Nura-Raie M; Tumbale SK; Allen R; Tam SM; Wu B; Liu C; Kheirolomoom A; Fite BZ; Ilovitsh A; Lewis JS; Ferrara KW
    Adv Healthc Mater; 2021 May; 10(10):e2100008. PubMed ID: 33646600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation.
    Bhagchandani SH; Vohidov F; Milling LE; Tong EY; Brown CM; Ramseier ML; Liu B; Fessenden TB; Nguyen HV; Kiel GR; Won L; Langer RS; Spranger S; Shalek AK; Irvine DJ; Johnson JA
    Sci Adv; 2023 Apr; 9(16):eadg2239. PubMed ID: 37075115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype.
    Sarkar B; Arlauckas SP; Cuccarese MF; Garris CS; Weissleder R; Rodell CB
    Front Immunol; 2024; 15():1331480. PubMed ID: 38545103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell-targeted polylactic acid nanoparticles as platform for encapsulating jakinibs: potential therapeutic strategy for systemic lupus erythematosus.
    Álvarez K; Palacio J; Agudelo NA; Anacona CA; Castaño D; Vásquez G; Rojas M
    Nanomedicine (Lond); 2023 Nov; 18(27):2001-2019. PubMed ID: 38084660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel nanoparticle degradation influences the activation and survival of primary macrophages.
    Jarai BM; Stillman Z; Fromen CA
    J Mater Chem B; 2021 Sep; 9(35):7246-7257. PubMed ID: 34226910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.